e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline
Arnaud Scherpereel (Lille, France)
Source:
ERS Webinars 2019 - Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline
Number:
0
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Arnaud Scherpereel (Lille, France). Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline. ERS Webinars 2019 - Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Diagnostic yield of combined epidemiological and radiological data in Malignant Pleural Mesothelioma: A Pilot Study
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019
Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline
Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis
Year: 2015
The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Source: Guideline 2018
Year: 2018
Malignant pleural mesothelioma: Current status and future projections in Turkey
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Haematologic parameters and their prognostic impact in malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Source: Guideline 2011
Year: 2011
Evaluation of New Biomarkers in Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Role of fibulin-3 in the diagnosis of malignant mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Thoracoscopy: Outcomes in non-diagnostic procedures
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Description of free-flowing pleural effusions in medical reports after echographic assessment: A proposal of standardization
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Malignant pleural mesothelioma: A retrospective analysis of 32 cases
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks
Source: Guideline 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept